Achieving lupus low-disease activity and remission states under belimumab in refractory systemic lupus erythematosus: time and organ involvement matter

Ann Rheum Dis. 2020 Nov;79(11):e148. doi: 10.1136/annrheumdis-2019-215732. Epub 2019 Jul 8.
No abstract available

Keywords: dmards (biologic); systemic lupus erythematosus; treatment.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Humans
  • Lupus Erythematosus, Systemic* / drug therapy


  • Antibodies, Monoclonal, Humanized
  • belimumab